Literature DB >> 25371187

Evidence of autochthonous Chagas disease in southeastern Texas.

Melissa N Garcia1, David Aguilar2, Rodion Gorchakov2, Susan N Rossmann2, Susan P Montgomery2, Hilda Rivera2, Laila Woc-Colburn2, Peter J Hotez2, Kristy O Murray2.   

Abstract

Autochthonous transmission of Trypanosoma cruzi in the United States is rarely reported. Here, we describe five newly identified patients with autochthonously acquired infections from a small pilot study of positive blood donors in southeast Texas. Case-patients 1-4 were possibly infected near their residences, which were all in the same region ∼100 miles west of Houston. Case-patient 5 was a young male with considerable exposure from routine outdoor and camping activities associated with a youth civic organization. Only one of the five autochthonous case-patients received anti-parasitic treatment. Our findings suggest an unrecognized risk of human vector-borne transmission in southeast Texas. Education of physicians and public health officials is crucial for identifying the true disease burden and source of infection in Texas. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25371187      PMCID: PMC4347336          DOI: 10.4269/ajtmh.14-0238

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.

Authors:  Paul T Cantey; Susan L Stramer; Rebecca L Townsend; Hany Kamel; Karen Ofafa; Charles W Todd; Mary Currier; Sheryl Hand; Wendy Varnado; Ellen Dotson; Chris Hall; Pamela L Jett; Susan P Montgomery
Journal:  Transfusion       Date:  2012-03-08       Impact factor: 3.157

2.  Perinatal Screening for Chagas Disease in Southern Texas.

Authors:  Morven S Edwards; Marcia A Rench; Charles W Todd; Nancy Czaicki; Francis J Steurer; Caryn Bern; Susan P Montgomery
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-03       Impact factor: 3.164

Review 3.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

Review 4.  American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States.

Authors:  L V Kirchhoff
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

5.  Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.

Authors:  Brian Custer; Maria Agapova; Roberta Bruhn; Robin Cusick; Hany Kamel; Peter Tomasulo; Hope Biswas; Leslie Tobler; Tzong-Hae Lee; Sally Caglioti; Michael Busch
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

6.  Physician awareness of Chagas disease, USA.

Authors:  Kelly K Stimpert; Susan P Montgomery
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

7.  Trypanosoma cruzi screening in Texas blood donors, 2008-2012.

Authors:  M N Garcia; L Woc-Colburn; S N Rossmann; R L Townsend; S L Stramer; M Bravo; H Kamel; R Beddard; M Townsend; R Oldham; M E Bottazzi; P J Hotez; K O Murray
Journal:  Epidemiol Infect       Date:  2014-08-29       Impact factor: 2.451

8.  An estimate of the burden of Chagas disease in the United States.

Authors:  Caryn Bern; Susan P Montgomery
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

9.  Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.

Authors:  Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy
Journal:  Circulation       Date:  2013-02-07       Impact factor: 29.690

10.  Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States.

Authors:  Melissa N Garcia; Peter J Hotez; Kristy O Murray
Journal:  Parasit Vectors       Date:  2014-07-04       Impact factor: 3.876

View more
  37 in total

1.  Identification of Triatomines and Their Habitats in a Highly Developed Urban Environment.

Authors:  Kyndall C Dye-Braumuller; Rodion Gorchakov; Sarah M Gunter; David H Nielsen; Walter D Roachell; Anna Wheless; Mustapha Debboun; Kristy O Murray; Melissa S Nolan
Journal:  Vector Borne Zoonotic Dis       Date:  2018-12-20       Impact factor: 2.133

2.  Access to care for Chagas disease in the United States: a health systems analysis.

Authors:  Jennifer Manne-Goehler; Michael R Reich; Veronika J Wirtz
Journal:  Am J Trop Med Hyg       Date:  2015-05-18       Impact factor: 2.345

Review 3.  Alterations in pancreatic β cell function and Trypanosoma cruzi infection: evidence from human and animal studies.

Authors:  Quinn Dufurrena; Farhad M Amjad; Philipp E Scherer; Louis M Weiss; Jyothi Nagajyothi; Jesse Roth; Herbert B Tanowitz; Regina Kuliawat
Journal:  Parasitol Res       Date:  2016-12-24       Impact factor: 2.289

4.  What Do We Know About Chagas Disease in the United States?

Authors:  Susan P Montgomery; Monica E Parise; Ellen M Dotson; Stephanie R Bialek
Journal:  Am J Trop Med Hyg       Date:  2016-07-11       Impact factor: 2.345

Review 5.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

6.  The Prevalence of Trypanosoma cruzi, the Causal Agent of Chagas Disease, in Texas Rodent Populations.

Authors:  Adriana Aleman; Trina Guerra; Troy J Maikis; Matthew T Milholland; Ivan Castro-Arellano; Michael R J Forstner; Dittmar Hahn
Journal:  Ecohealth       Date:  2017-01-13       Impact factor: 3.184

7.  Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Authors:  Romain A Colas; Anthony W Ashton; Shankar Mukherjee; Jesmond Dalli; Oscar B Akide-Ndunge; Huan Huang; Mahalia S Desruisseaux; Fangxia Guan; Linda A Jelicks; Fabiane Matos Dos Santos; Jyothi Nagajyothi; Michael A Zingman; Jinet Reyes; Louis M Weiss; Charles N Serhan; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 8.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

9.  Reproductive Outcomes in Rhesus Macaques (Macaca mulatta) with Naturally-acquired Trypanosoma cruzi Infection.

Authors:  April L Kendricks; Stanton B Gray; Gregory K Wilkerson; Courtney M Sands; Christian R Abee; Bruce J Bernacky; Peter J Hotez; Maria Elena Bottazzi; Suzanne L Craig; Kathryn M Jones
Journal:  Comp Med       Date:  2020-03-17       Impact factor: 0.982

Review 10.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.